nodes	percent_of_prediction	percent_of_DWPC	metapath
Etravirine—CYP2C19—Ifosfamide—testicular cancer	0.119	0.173	CbGbCtD
Etravirine—CYP2C9—Ifosfamide—testicular cancer	0.0993	0.144	CbGbCtD
Etravirine—ABCB1—Dactinomycin—testicular cancer	0.0816	0.118	CbGbCtD
Etravirine—CYP3A4—Ifosfamide—testicular cancer	0.0577	0.0838	CbGbCtD
Etravirine—ABCB1—Vinblastine—testicular cancer	0.0511	0.0742	CbGbCtD
Etravirine—CYP2C9—Cisplatin—testicular cancer	0.0483	0.0701	CbGbCtD
Etravirine—ABCB1—Cisplatin—testicular cancer	0.0469	0.068	CbGbCtD
Etravirine—ABCB1—Etoposide—testicular cancer	0.046	0.0668	CbGbCtD
Etravirine—ABCB1—Doxorubicin—testicular cancer	0.0314	0.0456	CbGbCtD
Etravirine—CYP3A4—Vinblastine—testicular cancer	0.0306	0.0444	CbGbCtD
Etravirine—ABCB1—Methotrexate—testicular cancer	0.0304	0.0441	CbGbCtD
Etravirine—CYP3A4—Etoposide—testicular cancer	0.0276	0.04	CbGbCtD
Etravirine—CYP3A4—Doxorubicin—testicular cancer	0.0188	0.0273	CbGbCtD
Etravirine—Abdominal pain—Ifosfamide—testicular cancer	0.000458	0.00147	CcSEcCtD
Etravirine—Body temperature increased—Ifosfamide—testicular cancer	0.000458	0.00147	CcSEcCtD
Etravirine—Infection—Etoposide—testicular cancer	0.000455	0.00146	CcSEcCtD
Etravirine—Abdominal distension—Epirubicin—testicular cancer	0.000454	0.00146	CcSEcCtD
Etravirine—Asthenia—Dactinomycin—testicular cancer	0.000454	0.00146	CcSEcCtD
Etravirine—Paraesthesia—Cisplatin—testicular cancer	0.000449	0.00144	CcSEcCtD
Etravirine—Thrombocytopenia—Etoposide—testicular cancer	0.000448	0.00144	CcSEcCtD
Etravirine—Eosinophilia—Epirubicin—testicular cancer	0.000447	0.00144	CcSEcCtD
Etravirine—Skin disorder—Etoposide—testicular cancer	0.000445	0.00143	CcSEcCtD
Etravirine—Dry skin—Doxorubicin—testicular cancer	0.000443	0.00142	CcSEcCtD
Etravirine—Hyperhidrosis—Etoposide—testicular cancer	0.000443	0.00142	CcSEcCtD
Etravirine—Pancreatitis—Epirubicin—testicular cancer	0.000442	0.00142	CcSEcCtD
Etravirine—Angina pectoris—Epirubicin—testicular cancer	0.00044	0.00141	CcSEcCtD
Etravirine—Breast disorder—Doxorubicin—testicular cancer	0.000437	0.0014	CcSEcCtD
Etravirine—Anorexia—Etoposide—testicular cancer	0.000436	0.0014	CcSEcCtD
Etravirine—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.000435	0.0014	CcSEcCtD
Etravirine—Decreased appetite—Cisplatin—testicular cancer	0.000434	0.0014	CcSEcCtD
Etravirine—Diarrhoea—Dactinomycin—testicular cancer	0.000433	0.00139	CcSEcCtD
Etravirine—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000431	0.00139	CcSEcCtD
Etravirine—Vomiting—Bleomycin—testicular cancer	0.000431	0.00139	CcSEcCtD
Etravirine—Rash—Bleomycin—testicular cancer	0.000428	0.00138	CcSEcCtD
Etravirine—Gastritis—Doxorubicin—testicular cancer	0.000428	0.00138	CcSEcCtD
Etravirine—Pain—Cisplatin—testicular cancer	0.000427	0.00137	CcSEcCtD
Etravirine—Dermatitis—Bleomycin—testicular cancer	0.000427	0.00137	CcSEcCtD
Etravirine—Hypersensitivity—Ifosfamide—testicular cancer	0.000427	0.00137	CcSEcCtD
Etravirine—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.000426	0.00137	CcSEcCtD
Etravirine—Renal failure—Methotrexate—testicular cancer	0.000423	0.00136	CcSEcCtD
Etravirine—Abdominal distension—Doxorubicin—testicular cancer	0.00042	0.00135	CcSEcCtD
Etravirine—Stomatitis—Methotrexate—testicular cancer	0.000419	0.00135	CcSEcCtD
Etravirine—Conjunctivitis—Methotrexate—testicular cancer	0.000418	0.00134	CcSEcCtD
Etravirine—Asthenia—Ifosfamide—testicular cancer	0.000416	0.00134	CcSEcCtD
Etravirine—Eosinophilia—Doxorubicin—testicular cancer	0.000413	0.00133	CcSEcCtD
Etravirine—Feeling abnormal—Cisplatin—testicular cancer	0.000412	0.00132	CcSEcCtD
Etravirine—Paraesthesia—Etoposide—testicular cancer	0.000411	0.00132	CcSEcCtD
Etravirine—Pancreatitis—Doxorubicin—testicular cancer	0.000409	0.00132	CcSEcCtD
Etravirine—Hyperglycaemia—Epirubicin—testicular cancer	0.000407	0.00131	CcSEcCtD
Etravirine—Somnolence—Etoposide—testicular cancer	0.000407	0.00131	CcSEcCtD
Etravirine—Angina pectoris—Doxorubicin—testicular cancer	0.000407	0.00131	CcSEcCtD
Etravirine—Hepatobiliary disease—Methotrexate—testicular cancer	0.000407	0.00131	CcSEcCtD
Etravirine—Nausea—Bleomycin—testicular cancer	0.000403	0.0013	CcSEcCtD
Etravirine—Vomiting—Dactinomycin—testicular cancer	0.000402	0.00129	CcSEcCtD
Etravirine—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000399	0.00128	CcSEcCtD
Etravirine—Rash—Dactinomycin—testicular cancer	0.000399	0.00128	CcSEcCtD
Etravirine—Decreased appetite—Etoposide—testicular cancer	0.000398	0.00128	CcSEcCtD
Etravirine—Diarrhoea—Ifosfamide—testicular cancer	0.000397	0.00128	CcSEcCtD
Etravirine—Renal failure—Epirubicin—testicular cancer	0.000396	0.00127	CcSEcCtD
Etravirine—Gastrointestinal disorder—Etoposide—testicular cancer	0.000395	0.00127	CcSEcCtD
Etravirine—Body temperature increased—Cisplatin—testicular cancer	0.000395	0.00127	CcSEcCtD
Etravirine—Fatigue—Etoposide—testicular cancer	0.000395	0.00127	CcSEcCtD
Etravirine—Neuropathy peripheral—Epirubicin—testicular cancer	0.000394	0.00127	CcSEcCtD
Etravirine—Stomatitis—Epirubicin—testicular cancer	0.000392	0.00126	CcSEcCtD
Etravirine—Constipation—Etoposide—testicular cancer	0.000391	0.00126	CcSEcCtD
Etravirine—Pain—Etoposide—testicular cancer	0.000391	0.00126	CcSEcCtD
Etravirine—Conjunctivitis—Epirubicin—testicular cancer	0.000391	0.00126	CcSEcCtD
Etravirine—Hepatitis—Methotrexate—testicular cancer	0.000386	0.00124	CcSEcCtD
Etravirine—Dizziness—Ifosfamide—testicular cancer	0.000383	0.00123	CcSEcCtD
Etravirine—Urinary tract disorder—Methotrexate—testicular cancer	0.000381	0.00123	CcSEcCtD
Etravirine—Hepatobiliary disease—Epirubicin—testicular cancer	0.000381	0.00122	CcSEcCtD
Etravirine—Urethral disorder—Methotrexate—testicular cancer	0.000378	0.00122	CcSEcCtD
Etravirine—Feeling abnormal—Etoposide—testicular cancer	0.000377	0.00121	CcSEcCtD
Etravirine—Hyperglycaemia—Doxorubicin—testicular cancer	0.000377	0.00121	CcSEcCtD
Etravirine—Nausea—Dactinomycin—testicular cancer	0.000376	0.00121	CcSEcCtD
Etravirine—Gastrointestinal pain—Etoposide—testicular cancer	0.000374	0.0012	CcSEcCtD
Etravirine—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000369	0.00119	CcSEcCtD
Etravirine—Vomiting—Ifosfamide—testicular cancer	0.000369	0.00119	CcSEcCtD
Etravirine—Hypersensitivity—Cisplatin—testicular cancer	0.000368	0.00118	CcSEcCtD
Etravirine—Renal failure—Doxorubicin—testicular cancer	0.000366	0.00118	CcSEcCtD
Etravirine—Rash—Ifosfamide—testicular cancer	0.000365	0.00118	CcSEcCtD
Etravirine—Dermatitis—Ifosfamide—testicular cancer	0.000365	0.00117	CcSEcCtD
Etravirine—Erythema multiforme—Methotrexate—testicular cancer	0.000365	0.00117	CcSEcCtD
Etravirine—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000365	0.00117	CcSEcCtD
Etravirine—Stomatitis—Doxorubicin—testicular cancer	0.000363	0.00117	CcSEcCtD
Etravirine—Abdominal pain—Etoposide—testicular cancer	0.000362	0.00116	CcSEcCtD
Etravirine—Body temperature increased—Etoposide—testicular cancer	0.000362	0.00116	CcSEcCtD
Etravirine—Conjunctivitis—Doxorubicin—testicular cancer	0.000362	0.00116	CcSEcCtD
Etravirine—Hepatitis—Epirubicin—testicular cancer	0.000361	0.00116	CcSEcCtD
Etravirine—Eye disorder—Methotrexate—testicular cancer	0.000361	0.00116	CcSEcCtD
Etravirine—Hypoaesthesia—Epirubicin—testicular cancer	0.000359	0.00116	CcSEcCtD
Etravirine—Asthenia—Cisplatin—testicular cancer	0.000359	0.00115	CcSEcCtD
Etravirine—Cardiac disorder—Methotrexate—testicular cancer	0.000358	0.00115	CcSEcCtD
Etravirine—Urinary tract disorder—Epirubicin—testicular cancer	0.000357	0.00115	CcSEcCtD
Etravirine—Connective tissue disorder—Epirubicin—testicular cancer	0.000355	0.00114	CcSEcCtD
Etravirine—Urethral disorder—Epirubicin—testicular cancer	0.000354	0.00114	CcSEcCtD
Etravirine—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000352	0.00113	CcSEcCtD
Etravirine—Angiopathy—Methotrexate—testicular cancer	0.00035	0.00113	CcSEcCtD
Etravirine—Immune system disorder—Methotrexate—testicular cancer	0.000349	0.00112	CcSEcCtD
Etravirine—Mediastinal disorder—Methotrexate—testicular cancer	0.000348	0.00112	CcSEcCtD
Etravirine—Nausea—Ifosfamide—testicular cancer	0.000344	0.00111	CcSEcCtD
Etravirine—Diarrhoea—Cisplatin—testicular cancer	0.000342	0.0011	CcSEcCtD
Etravirine—Erythema multiforme—Epirubicin—testicular cancer	0.000342	0.0011	CcSEcCtD
Etravirine—Mental disorder—Methotrexate—testicular cancer	0.000338	0.00109	CcSEcCtD
Etravirine—Eye disorder—Epirubicin—testicular cancer	0.000338	0.00109	CcSEcCtD
Etravirine—Hypersensitivity—Etoposide—testicular cancer	0.000337	0.00108	CcSEcCtD
Etravirine—Malnutrition—Methotrexate—testicular cancer	0.000336	0.00108	CcSEcCtD
Etravirine—Cardiac disorder—Epirubicin—testicular cancer	0.000335	0.00108	CcSEcCtD
Etravirine—Hepatitis—Doxorubicin—testicular cancer	0.000334	0.00107	CcSEcCtD
Etravirine—Hypoaesthesia—Doxorubicin—testicular cancer	0.000333	0.00107	CcSEcCtD
Etravirine—Urinary tract disorder—Doxorubicin—testicular cancer	0.00033	0.00106	CcSEcCtD
Etravirine—Asthenia—Etoposide—testicular cancer	0.000328	0.00106	CcSEcCtD
Etravirine—Connective tissue disorder—Doxorubicin—testicular cancer	0.000328	0.00106	CcSEcCtD
Etravirine—Angiopathy—Epirubicin—testicular cancer	0.000328	0.00105	CcSEcCtD
Etravirine—Urethral disorder—Doxorubicin—testicular cancer	0.000328	0.00105	CcSEcCtD
Etravirine—Immune system disorder—Epirubicin—testicular cancer	0.000326	0.00105	CcSEcCtD
Etravirine—Mediastinal disorder—Epirubicin—testicular cancer	0.000326	0.00105	CcSEcCtD
Etravirine—Vomiting—Cisplatin—testicular cancer	0.000318	0.00102	CcSEcCtD
Etravirine—Vision blurred—Methotrexate—testicular cancer	0.000317	0.00102	CcSEcCtD
Etravirine—Mental disorder—Epirubicin—testicular cancer	0.000316	0.00102	CcSEcCtD
Etravirine—Erythema multiforme—Doxorubicin—testicular cancer	0.000316	0.00102	CcSEcCtD
Etravirine—Rash—Cisplatin—testicular cancer	0.000315	0.00101	CcSEcCtD
Etravirine—Dermatitis—Cisplatin—testicular cancer	0.000315	0.00101	CcSEcCtD
Etravirine—Malnutrition—Epirubicin—testicular cancer	0.000314	0.00101	CcSEcCtD
Etravirine—Diarrhoea—Etoposide—testicular cancer	0.000313	0.00101	CcSEcCtD
Etravirine—Eye disorder—Doxorubicin—testicular cancer	0.000312	0.001	CcSEcCtD
Etravirine—Ill-defined disorder—Methotrexate—testicular cancer	0.000312	0.001	CcSEcCtD
Etravirine—Anaemia—Methotrexate—testicular cancer	0.000311	0.000999	CcSEcCtD
Etravirine—Cardiac disorder—Doxorubicin—testicular cancer	0.00031	0.000998	CcSEcCtD
Etravirine—Flatulence—Epirubicin—testicular cancer	0.00031	0.000997	CcSEcCtD
Etravirine—Tension—Epirubicin—testicular cancer	0.000309	0.000992	CcSEcCtD
Etravirine—Nervousness—Epirubicin—testicular cancer	0.000305	0.000982	CcSEcCtD
Etravirine—Angiopathy—Doxorubicin—testicular cancer	0.000303	0.000975	CcSEcCtD
Etravirine—Malaise—Methotrexate—testicular cancer	0.000303	0.000975	CcSEcCtD
Etravirine—Dizziness—Etoposide—testicular cancer	0.000303	0.000974	CcSEcCtD
Etravirine—Immune system disorder—Doxorubicin—testicular cancer	0.000302	0.000971	CcSEcCtD
Etravirine—Vertigo—Methotrexate—testicular cancer	0.000302	0.000971	CcSEcCtD
Etravirine—Mediastinal disorder—Doxorubicin—testicular cancer	0.000301	0.000969	CcSEcCtD
Etravirine—Nausea—Cisplatin—testicular cancer	0.000297	0.000955	CcSEcCtD
Etravirine—Vision blurred—Epirubicin—testicular cancer	0.000296	0.000953	CcSEcCtD
Etravirine—Mental disorder—Doxorubicin—testicular cancer	0.000293	0.000942	CcSEcCtD
Etravirine—Ill-defined disorder—Epirubicin—testicular cancer	0.000292	0.000938	CcSEcCtD
Etravirine—Convulsion—Methotrexate—testicular cancer	0.000291	0.000936	CcSEcCtD
Etravirine—Vomiting—Etoposide—testicular cancer	0.000291	0.000936	CcSEcCtD
Etravirine—Malnutrition—Doxorubicin—testicular cancer	0.000291	0.000936	CcSEcCtD
Etravirine—Anaemia—Epirubicin—testicular cancer	0.000291	0.000935	CcSEcCtD
Etravirine—Rash—Etoposide—testicular cancer	0.000289	0.000928	CcSEcCtD
Etravirine—Dermatitis—Etoposide—testicular cancer	0.000288	0.000928	CcSEcCtD
Etravirine—Headache—Etoposide—testicular cancer	0.000287	0.000922	CcSEcCtD
Etravirine—Flatulence—Doxorubicin—testicular cancer	0.000287	0.000922	CcSEcCtD
Etravirine—Tension—Doxorubicin—testicular cancer	0.000286	0.000918	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000284	0.000914	CcSEcCtD
Etravirine—Malaise—Epirubicin—testicular cancer	0.000284	0.000912	CcSEcCtD
Etravirine—Discomfort—Methotrexate—testicular cancer	0.000283	0.000909	CcSEcCtD
Etravirine—Nervousness—Doxorubicin—testicular cancer	0.000283	0.000909	CcSEcCtD
Etravirine—Vertigo—Epirubicin—testicular cancer	0.000283	0.000909	CcSEcCtD
Etravirine—Syncope—Epirubicin—testicular cancer	0.000282	0.000907	CcSEcCtD
Etravirine—Confusional state—Methotrexate—testicular cancer	0.000277	0.000889	CcSEcCtD
Etravirine—Loss of consciousness—Epirubicin—testicular cancer	0.000276	0.000889	CcSEcCtD
Etravirine—Vision blurred—Doxorubicin—testicular cancer	0.000274	0.000882	CcSEcCtD
Etravirine—Convulsion—Epirubicin—testicular cancer	0.000272	0.000876	CcSEcCtD
Etravirine—Infection—Methotrexate—testicular cancer	0.000272	0.000876	CcSEcCtD
Etravirine—Nausea—Etoposide—testicular cancer	0.000272	0.000875	CcSEcCtD
Etravirine—Hypertension—Epirubicin—testicular cancer	0.000271	0.000873	CcSEcCtD
Etravirine—Ill-defined disorder—Doxorubicin—testicular cancer	0.00027	0.000868	CcSEcCtD
Etravirine—Nervous system disorder—Methotrexate—testicular cancer	0.000269	0.000865	CcSEcCtD
Etravirine—Anaemia—Doxorubicin—testicular cancer	0.000269	0.000865	CcSEcCtD
Etravirine—Thrombocytopenia—Methotrexate—testicular cancer	0.000268	0.000864	CcSEcCtD
Etravirine—Anxiety—Epirubicin—testicular cancer	0.000267	0.000858	CcSEcCtD
Etravirine—Skin disorder—Methotrexate—testicular cancer	0.000266	0.000857	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000266	0.000855	CcSEcCtD
Etravirine—Hyperhidrosis—Methotrexate—testicular cancer	0.000265	0.000853	CcSEcCtD
Etravirine—Discomfort—Epirubicin—testicular cancer	0.000264	0.000851	CcSEcCtD
Etravirine—Malaise—Doxorubicin—testicular cancer	0.000262	0.000844	CcSEcCtD
Etravirine—Dry mouth—Epirubicin—testicular cancer	0.000262	0.000842	CcSEcCtD
Etravirine—Vertigo—Doxorubicin—testicular cancer	0.000261	0.000841	CcSEcCtD
Etravirine—Anorexia—Methotrexate—testicular cancer	0.000261	0.000841	CcSEcCtD
Etravirine—Syncope—Doxorubicin—testicular cancer	0.000261	0.000839	CcSEcCtD
Etravirine—Confusional state—Epirubicin—testicular cancer	0.000259	0.000832	CcSEcCtD
Etravirine—Loss of consciousness—Doxorubicin—testicular cancer	0.000256	0.000822	CcSEcCtD
Etravirine—Infection—Epirubicin—testicular cancer	0.000255	0.00082	CcSEcCtD
Etravirine—Shock—Epirubicin—testicular cancer	0.000252	0.000812	CcSEcCtD
Etravirine—Convulsion—Doxorubicin—testicular cancer	0.000252	0.000811	CcSEcCtD
Etravirine—Nervous system disorder—Epirubicin—testicular cancer	0.000252	0.000809	CcSEcCtD
Etravirine—Thrombocytopenia—Epirubicin—testicular cancer	0.000251	0.000808	CcSEcCtD
Etravirine—Hypertension—Doxorubicin—testicular cancer	0.000251	0.000808	CcSEcCtD
Etravirine—Skin disorder—Epirubicin—testicular cancer	0.000249	0.000802	CcSEcCtD
Etravirine—Hyperhidrosis—Epirubicin—testicular cancer	0.000248	0.000798	CcSEcCtD
Etravirine—Insomnia—Methotrexate—testicular cancer	0.000248	0.000798	CcSEcCtD
Etravirine—Anxiety—Doxorubicin—testicular cancer	0.000247	0.000794	CcSEcCtD
Etravirine—Paraesthesia—Methotrexate—testicular cancer	0.000246	0.000792	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000246	0.000791	CcSEcCtD
Etravirine—Discomfort—Doxorubicin—testicular cancer	0.000245	0.000787	CcSEcCtD
Etravirine—Anorexia—Epirubicin—testicular cancer	0.000245	0.000787	CcSEcCtD
Etravirine—Somnolence—Methotrexate—testicular cancer	0.000244	0.000784	CcSEcCtD
Etravirine—Dry mouth—Doxorubicin—testicular cancer	0.000242	0.000779	CcSEcCtD
Etravirine—Confusional state—Doxorubicin—testicular cancer	0.000239	0.00077	CcSEcCtD
Etravirine—Decreased appetite—Methotrexate—testicular cancer	0.000238	0.000767	CcSEcCtD
Etravirine—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000237	0.000761	CcSEcCtD
Etravirine—Fatigue—Methotrexate—testicular cancer	0.000236	0.00076	CcSEcCtD
Etravirine—Infection—Doxorubicin—testicular cancer	0.000236	0.000759	CcSEcCtD
Etravirine—Pain—Methotrexate—testicular cancer	0.000235	0.000754	CcSEcCtD
Etravirine—Shock—Doxorubicin—testicular cancer	0.000234	0.000751	CcSEcCtD
Etravirine—Nervous system disorder—Doxorubicin—testicular cancer	0.000233	0.000749	CcSEcCtD
Etravirine—Thrombocytopenia—Doxorubicin—testicular cancer	0.000232	0.000748	CcSEcCtD
Etravirine—Insomnia—Epirubicin—testicular cancer	0.000232	0.000747	CcSEcCtD
Etravirine—Skin disorder—Doxorubicin—testicular cancer	0.000231	0.000742	CcSEcCtD
Etravirine—Paraesthesia—Epirubicin—testicular cancer	0.00023	0.000741	CcSEcCtD
Etravirine—Hyperhidrosis—Doxorubicin—testicular cancer	0.00023	0.000738	CcSEcCtD
Etravirine—Somnolence—Epirubicin—testicular cancer	0.000228	0.000734	CcSEcCtD
Etravirine—Anorexia—Doxorubicin—testicular cancer	0.000226	0.000728	CcSEcCtD
Etravirine—Feeling abnormal—Methotrexate—testicular cancer	0.000226	0.000727	CcSEcCtD
Etravirine—Gastrointestinal pain—Methotrexate—testicular cancer	0.000224	0.000721	CcSEcCtD
Etravirine—Decreased appetite—Epirubicin—testicular cancer	0.000223	0.000717	CcSEcCtD
Etravirine—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000222	0.000713	CcSEcCtD
Etravirine—Fatigue—Epirubicin—testicular cancer	0.000221	0.000712	CcSEcCtD
Etravirine—Pain—Epirubicin—testicular cancer	0.000219	0.000706	CcSEcCtD
Etravirine—Constipation—Epirubicin—testicular cancer	0.000219	0.000706	CcSEcCtD
Etravirine—Abdominal pain—Methotrexate—testicular cancer	0.000217	0.000697	CcSEcCtD
Etravirine—Body temperature increased—Methotrexate—testicular cancer	0.000217	0.000697	CcSEcCtD
Etravirine—Insomnia—Doxorubicin—testicular cancer	0.000215	0.000691	CcSEcCtD
Etravirine—Paraesthesia—Doxorubicin—testicular cancer	0.000213	0.000686	CcSEcCtD
Etravirine—Feeling abnormal—Epirubicin—testicular cancer	0.000211	0.00068	CcSEcCtD
Etravirine—Somnolence—Doxorubicin—testicular cancer	0.000211	0.000679	CcSEcCtD
Etravirine—Gastrointestinal pain—Epirubicin—testicular cancer	0.00021	0.000675	CcSEcCtD
Etravirine—Decreased appetite—Doxorubicin—testicular cancer	0.000206	0.000664	CcSEcCtD
Etravirine—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000205	0.000659	CcSEcCtD
Etravirine—Fatigue—Doxorubicin—testicular cancer	0.000205	0.000658	CcSEcCtD
Etravirine—Constipation—Doxorubicin—testicular cancer	0.000203	0.000653	CcSEcCtD
Etravirine—Pain—Doxorubicin—testicular cancer	0.000203	0.000653	CcSEcCtD
Etravirine—Abdominal pain—Epirubicin—testicular cancer	0.000203	0.000652	CcSEcCtD
Etravirine—Body temperature increased—Epirubicin—testicular cancer	0.000203	0.000652	CcSEcCtD
Etravirine—Hypersensitivity—Methotrexate—testicular cancer	0.000202	0.00065	CcSEcCtD
Etravirine—Asthenia—Methotrexate—testicular cancer	0.000197	0.000633	CcSEcCtD
Etravirine—Feeling abnormal—Doxorubicin—testicular cancer	0.000196	0.000629	CcSEcCtD
Etravirine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000194	0.000624	CcSEcCtD
Etravirine—Hypersensitivity—Epirubicin—testicular cancer	0.000189	0.000608	CcSEcCtD
Etravirine—Abdominal pain—Doxorubicin—testicular cancer	0.000188	0.000604	CcSEcCtD
Etravirine—Body temperature increased—Doxorubicin—testicular cancer	0.000188	0.000604	CcSEcCtD
Etravirine—Diarrhoea—Methotrexate—testicular cancer	0.000188	0.000603	CcSEcCtD
Etravirine—Asthenia—Epirubicin—testicular cancer	0.000184	0.000592	CcSEcCtD
Etravirine—Dizziness—Methotrexate—testicular cancer	0.000181	0.000583	CcSEcCtD
Etravirine—Diarrhoea—Epirubicin—testicular cancer	0.000176	0.000565	CcSEcCtD
Etravirine—Hypersensitivity—Doxorubicin—testicular cancer	0.000175	0.000563	CcSEcCtD
Etravirine—Vomiting—Methotrexate—testicular cancer	0.000174	0.000561	CcSEcCtD
Etravirine—Rash—Methotrexate—testicular cancer	0.000173	0.000556	CcSEcCtD
Etravirine—Dermatitis—Methotrexate—testicular cancer	0.000173	0.000556	CcSEcCtD
Etravirine—Headache—Methotrexate—testicular cancer	0.000172	0.000553	CcSEcCtD
Etravirine—Asthenia—Doxorubicin—testicular cancer	0.00017	0.000548	CcSEcCtD
Etravirine—Dizziness—Epirubicin—testicular cancer	0.00017	0.000546	CcSEcCtD
Etravirine—Vomiting—Epirubicin—testicular cancer	0.000163	0.000525	CcSEcCtD
Etravirine—Nausea—Methotrexate—testicular cancer	0.000163	0.000524	CcSEcCtD
Etravirine—Diarrhoea—Doxorubicin—testicular cancer	0.000162	0.000523	CcSEcCtD
Etravirine—Rash—Epirubicin—testicular cancer	0.000162	0.00052	CcSEcCtD
Etravirine—Dermatitis—Epirubicin—testicular cancer	0.000162	0.00052	CcSEcCtD
Etravirine—Headache—Epirubicin—testicular cancer	0.000161	0.000517	CcSEcCtD
Etravirine—Dizziness—Doxorubicin—testicular cancer	0.000157	0.000505	CcSEcCtD
Etravirine—Nausea—Epirubicin—testicular cancer	0.000152	0.00049	CcSEcCtD
Etravirine—Vomiting—Doxorubicin—testicular cancer	0.000151	0.000486	CcSEcCtD
Etravirine—Rash—Doxorubicin—testicular cancer	0.00015	0.000482	CcSEcCtD
Etravirine—Dermatitis—Doxorubicin—testicular cancer	0.00015	0.000481	CcSEcCtD
Etravirine—Headache—Doxorubicin—testicular cancer	0.000149	0.000478	CcSEcCtD
Etravirine—Nausea—Doxorubicin—testicular cancer	0.000141	0.000454	CcSEcCtD
